SRRA

Sierra Oncology, Inc. Common Stock
SRRA

Overview Fund Activity
Delisted

SRRA was delisted on the 30th of June, 2022.

Back to rankings

34 hedge funds and large institutions have $169M invested in Sierra Oncology, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 12 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
34
Holders Change
+1
Holders Change %
+3.03%
% of All Funds
0.59%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
3
Increased
12
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
IC
Ikarian Capital
Texas
$10.6M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
$16.3M
3
Northern Trust
Northern Trust
Illinois
$750K
4
BlackRock
BlackRock
New York
$419K
5
OM
Opaleye Management
Massachusetts
$3.22M

Top Sellers

1
Millennium Management
Millennium Management
New York
$2.07M
2
TI
Telemetry Investments
New York
$241K
3
BCM
Bridgeway Capital Management
Texas
$1.18M
4
PVI
Pura Vida Investments
New York
$1.46M
5
Renaissance Technologies
Renaissance Technologies
New York
$2.07M
Name Holding Trade Value Shares
Change 		Shares
Change %
Royal Bank of Canada
26
Royal Bank of Canada
Ontario, Canada
$41K – – –
Wells Fargo
27
Wells Fargo
California
$23K +$19.2K +1,000 +500%
EWM
28
Elmwood Wealth Management
California
$20K – – –
Osaic Holdings
29
Osaic Holdings
Arizona
$15K +$12.8K +655 +580%
SB
30
Strategic Blueprint
Georgia
$15K +$15K +782 New
Group One Trading
31
Group One Trading
Illinois
$4K – – –
SCM
32
Silverarc Capital Management
Massachusetts
$2.71K +$90 +4,624 +3%
RE
33
RBC Europe
United Kingdom
$467 – – –
SFS
34
Sowell Financial Services
Arkansas
– -$16K -871 Closed
TRCT
35
Tower Research Capital (TRC)
New York
– -$7K -388 Closed
1
2